ES8801929A1 - Un procedimiento para preparar esteroido (3,2,-c) pirazoles - Google Patents

Un procedimiento para preparar esteroido (3,2,-c) pirazoles

Info

Publication number
ES8801929A1
ES8801929A1 ES557699A ES557699A ES8801929A1 ES 8801929 A1 ES8801929 A1 ES 8801929A1 ES 557699 A ES557699 A ES 557699A ES 557699 A ES557699 A ES 557699A ES 8801929 A1 ES8801929 A1 ES 8801929A1
Authority
ES
Spain
Prior art keywords
pyrazoles
procedure
r17alfa
chfc
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES557699A
Other languages
English (en)
Other versions
ES557699A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STWB Inc
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of ES557699A0 publication Critical patent/ES557699A0/es
Publication of ES8801929A1 publication Critical patent/ES8801929A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • C07J71/0047—Nitrogen only at position 2(3)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)

Abstract

LOS ESTEROIDO-3,2-C-PIRAZONES (1), DONDE NO EXHAUSTIVAMENTE, X ES ALQUILO C1-3, Y-Z ES CHFC, CFC,CH3, R6, R10 Y R17ALFA SON H O CH3 Y R17BETA ES OH O OCOCHCL2 SE PREPARAN POR CONDENSACION DE UN COMPUESTO (II) DONDE RK ES CH3 O CH3CH2 CON OTRO DE FORMULA XSO2NHNH2 EN PIRIDINA, CON AGITACION EN UN BAÑO DE HIELO Y OPCIONALMENTE: A) HIDROGENAR EL COMPUESTO (I) PARA PASAR EL R17ALFA DE CHFCH2 A CH2CH3; Y B) EPOXIDAR CON UN PERACIDO PARA PASAR Y-Z DE CHFC CHO-C. LOS COMPUESTOS (I) EXHIBEN PROPIEDADES ANTIANDROGENICAS.
ES557699A 1985-06-24 1987-08-31 Un procedimiento para preparar esteroido (3,2,-c) pirazoles Expired ES8801929A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74837885A 1985-06-24 1985-06-24
US06/849,582 US4684636A (en) 1985-06-24 1986-04-08 Antiandrogenic sulfonylsteroidopyrazoles and processes for preparation method of use and compositions thereof

Publications (2)

Publication Number Publication Date
ES557699A0 ES557699A0 (es) 1988-03-01
ES8801929A1 true ES8801929A1 (es) 1988-03-01

Family

ID=27114932

Family Applications (2)

Application Number Title Priority Date Filing Date
ES556422A Expired ES8800690A1 (es) 1985-06-24 1986-06-23 Un procedimiento para preparar esteroido (3,2-c)pirazoles
ES557699A Expired ES8801929A1 (es) 1985-06-24 1987-08-31 Un procedimiento para preparar esteroido (3,2,-c) pirazoles

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES556422A Expired ES8800690A1 (es) 1985-06-24 1986-06-23 Un procedimiento para preparar esteroido (3,2-c)pirazoles

Country Status (19)

Country Link
US (1) US4684636A (es)
EP (1) EP0207375B1 (es)
KR (1) KR910002228B1 (es)
AR (2) AR242798A1 (es)
AT (1) ATE45164T1 (es)
AU (1) AU581767B2 (es)
CA (1) CA1255294A (es)
DE (1) DE3664775D1 (es)
DK (1) DK293786A (es)
ES (2) ES8800690A1 (es)
FI (1) FI83425C (es)
GR (1) GR861613B (es)
IL (1) IL79046A0 (es)
MY (1) MY101921A (es)
NO (1) NO166039C (es)
NZ (1) NZ216438A (es)
PH (1) PH22087A (es)
PT (1) PT82837B (es)
ZA (1) ZA864199B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5134135A (en) * 1990-06-21 1992-07-28 Sterling Drug Inc. Antiandrogenic sulfonylsteroidooxazoles
US5100882A (en) * 1990-06-21 1992-03-31 Sterling Drug Inc. Antiandrogenic sulfonylsteroidofurans
US5053405A (en) * 1990-06-21 1991-10-01 Sterling Drug Inc. Antiandrogenic sulfonylsteroidothiazoles
DE4021433A1 (de) * 1990-07-04 1992-01-09 Schering Ag Antiandrogene mit steroid(3,2-c)pyrazol-struktur
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions
US5175155A (en) * 1991-10-07 1992-12-29 Sterling Winthrop Inc. Win 49596-finasteride method of use and compositions
DE4227465A1 (de) * 1992-08-17 1994-02-24 Schering Ag Antiandrogene Steroide mit aneliertem Fünfring
CA2430288C (en) * 2000-12-01 2009-03-10 Kyowa Hakko Kogyo Co., Ltd. A composition improved in the solubility or oral absorbability

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL237293A (es) * 1959-02-16
US2945852A (en) * 1959-05-20 1960-07-19 Searle & Co 17-oxygenated 9alpha-substituted androstano [3, 2-c] pyrazoles and derivatives
US4356175A (en) * 1978-10-10 1982-10-26 The Upjohn Company 17β-Hydroxy-17α-methyl-5α-androstano-[3,2-c]pyrazole 17-methyl ether
US4297350A (en) * 1978-10-10 1981-10-27 The Upjohn Company Male contraceptive steroids and methods of use

Also Published As

Publication number Publication date
FI862637A0 (fi) 1986-06-19
KR870010074A (ko) 1987-11-30
EP0207375B1 (en) 1989-08-02
NO166039B (no) 1991-02-11
GR861613B (en) 1986-10-30
FI83425C (fi) 1991-07-10
ZA864199B (en) 1987-01-28
MY101921A (en) 1992-02-15
US4684636A (en) 1987-08-04
NZ216438A (en) 1989-01-06
FI83425B (fi) 1991-03-28
NO166039C (no) 1991-05-29
AR243201A1 (es) 1993-07-30
CA1255294A (en) 1989-06-06
ATE45164T1 (de) 1989-08-15
PH22087A (en) 1988-05-20
ES8800690A1 (es) 1987-11-16
ES557699A0 (es) 1988-03-01
ES556422A0 (es) 1987-11-16
KR910002228B1 (ko) 1991-04-08
DE3664775D1 (en) 1989-09-07
DK293786D0 (da) 1986-06-23
PT82837A (en) 1986-07-01
PT82837B (pt) 1988-04-21
DK293786A (da) 1986-12-25
NO862506D0 (no) 1986-06-23
NO862506L (no) 1986-12-29
FI862637L (fi) 1986-12-25
AR242798A1 (es) 1993-05-31
AU5896586A (en) 1987-01-08
EP0207375A1 (en) 1987-01-07
IL79046A0 (en) 1986-09-30
AU581767B2 (en) 1989-03-02

Similar Documents

Publication Publication Date Title
KR870006039A (ko) 신규 티아졸 화합물, 그 제조방법 및 이 화합물을 함유하는 약학적 조성물
IL57691A (en) Delta-4,9-gonadiene-21-ol-3,20-diones,process for preparing them and pharmaceutical compositions containing them
ES483854A1 (es) Proceso para la obtencion de un derivado de 2-deoxi-5-fluo- rouridina.
ZA858418B (en) 5-alkyl-1-phenyl-2-piperazinoalkylpyrazoline-3-one compounds and methods for the preparation thereof,intermediates for use in the preparation of said compounds and medicaments containing said compounds
ES2000613A6 (es) Metodo de preparar nuevos esteroides
ES451564A1 (es) Un procedimiento para la preparacion de una composicion de champu liquida, muy viscosa y transparente.
KR840005122A (ko) 메틸플라본 유도체의 제조방법
KR900004697A (ko) 고콜레스테롤 혈증치료용 4,5-디아릴-2- 치환된 티오이미다졸
KR860003202A (ko) 요오드 트리아미노벤젠 화합물의 제조방법
KR840005717A (ko) 벤즈아미드 유도체의 제조방법
KR830001900A (ko) 페닐모르판과 그의 중간물질및 제조방법
PL244185A1 (en) Process for preparing novel substituted thiazolidinyl esters of mineral acids
KR880002843A (ko) 3-퍼플루오로알킬-5-치환된-옥시-이속사졸 유도체, 그의 제조방법, 및 그를 함유하는 제초제
GB1088356A (en) N-benzodioxanyl carbamates
ES8207181A1 (es) Procedimiento para la fabricacion de derivados de 5,6,7,7atetrahidro-4h-tieno(3,2-c)-piridin-2-ona .
EP0139907A3 (en) Estrane derivatives
DE3679091D1 (de) Herstellung von thienoimidazolderivaten.
ES421511A1 (es) Un procedimiento de preparacion de nuevos 2,2-dimetil-este-roides.
ES8505656A1 (es) Procedimiento para la preparacion de quinolinonas-4
US4257982A (en) 2-Decarboxy-2-aminomethyl-19,20-didehydro-13,14-dihydro-PG2 compounds
US4278813A (en) 19,20-Didehydro-13,14-dihydro-PG2, sulfonyl amides
US4264523A (en) 19,20-Didehydro-13,14-dihydro-PG1 amides
US4276434A (en) 19,20-Didehydro-13,14-dihydro-PG1, sulfonyl amides
US4283351A (en) 19,20-Didehydro-13,14-dihydro-PG2 amides
ES467409A1 (es) Procedimiento de preparacion de derivados de la ajmalicina.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303